Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study
- PMID: 33605016
- PMCID: PMC8360126
- DOI: 10.1111/1471-0528.16668
Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study
Abstract
Objective: To compare outcomes before and after implementation of medical abortion (termination of pregnancy) without ultrasound via telemedicine.
Design: Cohort analysis.
Setting: The three main abortion providers.
Population or sample: Medical abortions at home at ≤69 days' gestation in two cohorts: traditional model (in-person with ultrasound, n = 22 158) from January to March 2020 versus telemedicine-hybrid model (either in person or via telemedicine without ultrasound, n = 29 984, of whom 18 435 had no-test telemedicine) between April and June 2020. Sample (n = 52 142) comprises 85% of all medical abortions provided nationally.
Methods: Data from electronic records and incident databases were used to compare outcomes between cohorts, adjusted for baseline differences.
Main outcome measures: Treatment success, serious adverse events, waiting times, gestation at treatment, acceptability.
Results: Mean waiting time from referral to treatment was 4.2 days shorter in the telemedicine-hybrid model and more abortions were provided at ≤6 weeks' gestation (40% versus 25%, P < 0.001). Treatment success (98.8% versus 98.2%, P > 0.999), serious adverse events (0.02% versus 0.04%, P = 0.557) and incidence of ectopic pregnancy (0.2% versus 0.2%, P = 0.796) were not different between models. In the telemedicine-hybrid model, 0.04% were estimated to be over 10 weeks' gestation at the time of the abortion; all were completed safely at home. Within the telemedicine-hybrid model, effectiveness was higher with telemedicine than in-person care (99.2% versus 98.1%, P < 0.001). Acceptability of telemedicine was high (96% satisfied) and 80% reported a future preference for telemedicine.
Conclusions: A telemedicine-hybrid model for medical abortion that includes no-test telemedicine and treatment without an ultrasound is effective, safe, acceptable and improves access to care.
Tweetable abstract: Compelling evidence from 52 142 women shows no-test telemedicine abortion is safe, effective and improves care.
Keywords: Abortion; ambulatory care facilities [N02.278.035]; health planning [N03.349]; induced [E04.520.050]; mifepristone [D04.210.500.365.415.580]; misoprostol [D23.469.700.660.500]; pregnancy complications [C13.703]; telemedicine [N04.590.374.800]; termination of pregnancy.
© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Figures


Comment in
-
Induced abortion via telemedicine should become the norm: a commentary.BJOG. 2021 Aug;128(9):1475-1476. doi: 10.1111/1471-0528.16740. Epub 2021 Jun 7. BJOG. 2021. PMID: 33982401 No abstract available.
Similar articles
-
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.BJOG. 2021 Oct;128(11):1752-1761. doi: 10.1111/1471-0528.16813. Epub 2021 Jul 27. BJOG. 2021. PMID: 34138505 Free PMC article.
-
Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic.BMJ Sex Reprod Health. 2021 Oct;47(4):246-251. doi: 10.1136/bmjsrh-2020-200976. Epub 2021 Feb 4. BMJ Sex Reprod Health. 2021. PMID: 33542062 Free PMC article.
-
Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.Contraception. 2021 Jul;104(1):49-53. doi: 10.1016/j.contraception.2021.03.025. Epub 2021 Mar 28. Contraception. 2021. PMID: 33789080 Free PMC article.
-
Telemedicine for medical abortion: a systematic review.BJOG. 2019 Aug;126(9):1094-1102. doi: 10.1111/1471-0528.15684. Epub 2019 Apr 25. BJOG. 2019. PMID: 30869829 Free PMC article.
-
Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.Am J Obstet Gynecol. 2020 Jun;222(6):551-563.e13. doi: 10.1016/j.ajog.2019.11.1244. Epub 2019 Nov 9. Am J Obstet Gynecol. 2020. PMID: 31715147
Cited by
-
Acceptance and use of mobile health technology in post-abortion care.BMC Health Serv Res. 2024 Sep 27;24(1):1130. doi: 10.1186/s12913-024-11633-5. BMC Health Serv Res. 2024. PMID: 39334105 Free PMC article.
-
Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy.Acta Obstet Gynecol Scand. 2023 May;102(5):541-548. doi: 10.1111/aogs.14549. Epub 2023 Mar 18. Acta Obstet Gynecol Scand. 2023. PMID: 36933004 Free PMC article.
-
Patient Acceptability of Telehealth Medication Abortion Care in the United States, 2021‒2022: A Cohort Study.Am J Public Health. 2024 Feb;114(2):241-250. doi: 10.2105/AJPH.2023.307437. Epub 2024 Jan 18. Am J Public Health. 2024. PMID: 38237103 Free PMC article.
-
Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US.JAMA Netw Open. 2021 May 3;4(5):e2111852. doi: 10.1001/jamanetworkopen.2021.11852. JAMA Netw Open. 2021. PMID: 34019085 Free PMC article.
-
Early telemedical abortion, safeguarding, and under 18s: a qualitative study with care providers in England and Wales.BMJ Sex Reprod Health. 2023 Oct;49(4):238-244. doi: 10.1136/bmjsrh-2022-201762. Epub 2023 Jan 27. BMJ Sex Reprod Health. 2023. PMID: 36707235 Free PMC article.
References
-
- Bearak J, Popinchalk A, Ganatra B, Moller A‐B, Tunçalp Ö, Beavin C, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Global Health 2020;8:e1152–61. - PubMed
-
- Regan L, Glasier A. The British 1967 Abortion Act – still fit for purpose? Lancet 2017;390:1936–7. - PubMed
-
- National Institute for Health and Care Excellence (NICE) . Abortion Care. Evidence Review A – Accessibility and Sustainability of Abortion Services. London: National Institute for Health and Care Excellence (NICE); 2019. [www.nice.org.uk/guidance/ng140/documents/evidence‐review]. - PubMed
-
- O’Shea LE, Hawkins JE, Lord J, Schmidt‐Hansen M, Hasler E, Cameron S, et al. Access to and sustainability of abortion services: a systematic review and meta‐analysis for the National Institute of Health and Care Excellence – new clinical guidelines for England. Hum Reprod Update 2020;26:886–903. - PubMed
-
- WHO Global Observatory for eHealth . Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth. Geneva: World Health Organization; 2010.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous